XTL Biopharmaceuticals Ltd. (XTLB)
2.53
-0.25
(-8.99%)
USD |
NASDAQ |
Aug 24, 16:00
2.53
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Market Cap : 5.985M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.576M |
| August 20, 2026 | 6.534M |
| August 19, 2026 | 7.050M |
| August 18, 2026 | 7.641M |
| August 17, 2026 | 6.151M |
| August 14, 2026 | 6.588M |
| August 13, 2026 | 6.624M |
| August 12, 2026 | 6.364M |
| August 11, 2026 | 6.269M |
| August 10, 2026 | 6.789M |
| August 07, 2026 | 6.955M |
| August 06, 2026 | 6.789M |
| August 05, 2026 | 6.742M |
| August 04, 2026 | 6.813M |
| August 03, 2026 | 6.768M |
| July 31, 2026 | 6.671M |
| July 30, 2026 | 6.742M |
| July 29, 2026 | 7.001M |
| July 28, 2026 | 7.002M |
| July 27, 2026 | 6.813M |
| July 24, 2026 | 6.955M |
| July 23, 2026 | 6.860M |
| July 22, 2026 | 6.908M |
| July 21, 2026 | 6.908M |
| July 20, 2026 | 6.837M |
| Date | Value |
|---|---|
| July 17, 2026 | 6.718M |
| July 16, 2026 | 6.695M |
| July 15, 2026 | 6.931M |
| July 14, 2026 | 7.002M |
| July 13, 2026 | 6.813M |
| July 10, 2026 | 6.884M |
| July 09, 2026 | 6.837M |
| July 08, 2026 | 6.860M |
| July 07, 2026 | 7.050M |
| July 06, 2026 | 7.428M |
| July 02, 2026 | 6.387M |
| July 01, 2026 | 5.487M |
| June 30, 2026 | 6.016M |
| June 29, 2026 | 5.200M |
| June 26, 2026 | 5.200M |
| June 25, 2026 | 5.652M |
| June 24, 2026 | 6.144M |
| June 23, 2026 | 6.148M |
| June 22, 2026 | 5.950M |
| June 18, 2026 | 5.597M |
| June 17, 2026 | 5.332M |
| June 16, 2026 | 5.244M |
| June 15, 2026 | 5.068M |
| June 12, 2026 | 4.694M |
| June 11, 2026 | 5.156M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 12.18M |
| Kamada Ltd. | 485.79M |
| Can-Fite BioPharma Ltd. | 4.298M |
| Galmed Pharmaceuticals Ltd. | 3.316M |
| Revium Recovery, Inc. | 86.84M |
Market Cap Related Metrics
| Price | 2.53 |